First-Line Treatment of Patients With Indolent Non-Hodgkin...

  • Main
  • 2019 / 02
  • First-Line Treatment of Patients With Indolent Non-Hodgkin...
Journal of Clinical Oncology 2019 / 02

First-Line Treatment of Patients With Indolent Non-Hodgkin Lymphoma or Mantle-Cell Lymphoma With Bendamustine Plus Rituximab Versus R-CHOP or R-CVP: Results of the BRIGHT 5-Year Follow-Up Study

Flinn, Ian W., van der Jagt, Richard, Kahl, Brad, Wood, Peter, Hawkins, Tim, MacDonald, David, Simpson, David, Kolibaba, Kathryn, Issa, Samar, Chang, Julie, Trotman, Judith, Hallman, Doreen, Chen, Lin
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Language:
english
Journal:
Journal of Clinical Oncology
DOI:
10.1200/JCO.18.00605
Date:
February, 2019
File:
PDF, 722 KB
english, 2019
Conversion to is in progress
Conversion to is failed